Smartwatch Measurement of VO2 Max in ACHD Patients

Exploring the challenges and benefits of using smartwatches to measure VO2 max in patients with congenital heart disease. Discussing the intricacies of establishing normal standards in this diverse patient group and the potential of smartwatches in providing valuable prognostic information. Analyzing the correlation between smartwatch and CPAT-derived VO2 max, highlighting key factors that influence accurate measurements in ACHD patients.